Skip to content

Inventories at other companies

OSI Systems logo
OSI SystemsOSIS
$435.29M-0.8%
iRadimed logo
iRadimedIRMD
$12.45M+18.0%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$61.34M-11.3%
Butterfly Network logo
Butterfly NetworkBFLY
$59.3M-14.4%
QT Imaging Holdings, Inc. logo
QT Imaging Holdings, Inc.QTI
$6.83M+138%
Danaher logo
DanaherDHR
$2.61B+3.0%

Other financials

Income statement

See full
Revenue$5.1B+7.4%
Gross profit$2.0B-1.7%
Operating income$515.0M-18.1%
Net income$389.0M-31.0%
EPS (diluted)$0.85-30.9%

Balance sheet

See full
Total debt$10.6B+15.2%
Total equity$10.7B+16.1%
Total assets$37.1B+10.5%

Cash flow

See full
Operating cash flow$290.0M+16.0%
CapEx$178.0M+17.1%
Free cash flow$112.0M+14.3%

Valuation

See full
Market cap$29.12B-15.1%
P/E15.2×-0.1×
P/S1.4×-0.3×

Profitability

See full
Gross margin39.1%-2.9pp
Operating margin12.6%-1.1pp
Net margin9.1%-1.9pp
FCF margin7.2%

Returns & leverage

See full
Return on equity19.2%-7.1pp
Debt / equity0.0×
Current ratio1.2×+0.2×

Where this comes from

Reported directly by GE HealthCare Technologies in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about GE HealthCare Technologies's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GE HealthCare Technologies's inventories?
GE HealthCare Technologies (GEHC) reported inventories of $2.35B in Q1 2026.
How has GE HealthCare Technologies's inventories changed year-over-year?
GE HealthCare Technologies's inventories increased by 9.0% year-over-year, from $2.16B to $2.35B.
What is the long-term trend for GE HealthCare Technologies's inventories?
Over 4 years (2021 to 2025), GE HealthCare Technologies's inventories has grown at a 113.1% compound annual growth rate (CAGR), from $435M to $8.98B.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.